This inventor holds 1 USPTO granted patent. Top assignee: Regents of the University of Minnesota. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovative Contributions of Joel W. Slaton
Introduction
Joel W. Slaton is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical research, particularly in cancer therapy. His work focuses on innovative methods to inhibit tumor growth through targeted therapies.
Latest Patents
Joel W. Slaton holds a patent for "Casein kinase 2 antisense therapy." This invention provides antisense oligonucleotides that hybridize to casein kinase 2 nucleic acid sequences. The methods outlined in this patent aim to inhibit the expression of casein kinase 2, which can lead to a reduction in the size of solid tumors. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Slaton is affiliated with the University of Minnesota, where he conducts research and develops innovative therapies. His work has garnered attention for its potential impact on cancer treatment. He is dedicated to improving patient outcomes through scientific advancements.
Collaborations
Throughout his career, Joel has collaborated with esteemed colleagues, including Khalil Ahmed and Gretchen M. Unger. These partnerships have contributed to the development of his groundbreaking research and inventions.
Conclusion
Joel W. Slaton's contributions to the field of cancer therapy through his innovative patent demonstrate his dedication to medical research. His work continues to inspire advancements in the treatment of solid tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile